"Designing Growth Strategies is in our DNA"
Collagen is one of the significant proteins of the connective tissues of animals, such as the cornea, bones, skin, tendons, blood vessels, and teeth. Atelocollagen is, however, a derivative of collagen prepared by the treatment of pepsin, which cleaves telopeptide at both terminal ends of each collagen, releasing atelocollagen. The use of purified atelocollagen in therapeutic applications as well as in cosmetic preparation has been escalating and diversifying continuously. It is also used in a molded form containing medicine for slow-release preparations. Moreover, the demand for the solubilized atelocollagen that has the potential to aid the injured tissues is likely to propel the growth of the market.
Key Market Driver -
High moldability and high demand in pharmaceutical & biotechnology industry is likely to boost the market
Key Market Restraint -
Complexity involved in process of extraction is likely to hinder the market growth.
Atelocollagen can be used in skincare products due to its significant moisture retaining capacity. Atelocollagen is highly elastic and fibrous in nature, making it moldable into different forms such as gel, powder, films, and sponge-like structure, etc. allowing its use in various applications. Moreover, its low antigenic property allows atelocollagen to be used in cell culture, organ and tissue regeneration can be considered as the latest trend in atelocollagen industrial use, which is further expected to propel the demand for atelocollagen across the globe. Furthermore, factors like the technological advancements that allow the study and effect of atelocollagen at the cellular level and to introduce new products every time are further expected to drive the growth of the market. The increasing use of atelocollagen in medical science and medical devices to deliver aqueous collagen is likely to open a new gateway of opportunities for the market.
However, the complexity involved in the process of extraction and the efforts to maintain its soluble form of collagen are projected to hinder the market growth.
The global atelocollagen market is expected to be segmented based on source, end-users/applications, and region. Based on the source, the market can be segmented into bovine collagen, porcine collagen and others. Based on the end users/applications, the market can be segmented into cosmetic industries, medical devices, pharmaceutical & biotechnology industries, and others.
Geographically, the atelocollagen market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The major companies in the global atelocollagen report include Integra LifeSciences Corporation, Innocoll Holdings Limited, KOKEN CO. LTD., DSM, Collagen Matrix, Inc., EnColl, Collagen Solutions Plc., and other prominent players.
Geographically, the global atelocollagen market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The European region is expected to dominate the atelocollagen market due to the presence of the abundant meat processing industries and a substantial number of slaughterhouses, that in turn, is projected to have encouraged atelocollagen manufacturers to set up their plants in this regions.
To gain extensive insights into the market, Request for Customization
The North America region is anticipated to be the second dominating region owing to the massive presence of atelocollagen producers and due to the increase in the use of atelocollagen among end-use industries. The Asia Pacific is estimated to arise as the most lucrative region over the forecast period. This region demonstrates the presence of a well-recognized meat processing industry, together with high spending on industrial expansion by government agencies to push economic development. In addition to that, enormous investments in research and development enterprise to produce collagen-based products are further expected to favor market growth.
ATTRIBUTE | DETAILS |
By Source |
|
By End-Users |
|
By Geography |
|
US +1 833 909 2966 ( Toll Free )